TEDCO Announces Investment in Impruvon Health

Maryland-based technology company offering a platform to improve medication management care

COLUMBIA, Md. (February 5, 2024) – TEDCO, Maryland’s economic engine for technology companies, announced a recent $300,000 Seed Funds investment into Impruvon Health, a startup company focused on improving medication management by simplifying the complicated manual workflows through their connected and automated medication platform. TEDCO’s Seed Funds umbrella includes TEDCO’s Cybersecurity Investment Fund, a fund focused on investing in cybersecurity and information technology companies, like Impruvon Health.

“Impruvon Health works to simplify a stressful, time consuming and error-prone process in long term care – medication management. Our mission is to make these processes achievable, enabling operators to operate at full capacity, teams to provide great care, and improve outcomes for residents and drive independence for those that strive for it,” said Justin Amoyal, founder and CEO of Impruvon Health. “Thanks to TEDCO’s investment, we can expand on our efforts to promote higher quality care and medication management efficiency.”

Impruvon Health, based in Baltimore, Md., is a medication workflow automation platform aiming to stop medication errors, streamline management processes, and support regulatory compliance nationwide through smart medication workflow automation. The platform offers tools that may assist enterprise settings in optimizing the process, maximizing staff performance and enabling independence for individuals supported such as those with intellectual and developmental disabilities who strive to self-administer their own medications rather than relying on staff.

“By working to optimize medication management in enterprise care environments like assisted living facilities, group homes, or skilled nursing facilities, Impruvon Health is working to raise the bar, optimize enterprise care environments and hopefully grow the healthcare and technology ecosystems in Maryland,” said Teddy Gresser, director of TEDCO’s Seed Funds. “With TEDCO’s investment, Impruvon Health can continue supporting their initiatives in providing solutions in the medication management sector.”

TEDCO’s Seed Funds invest in companies that show promise of becoming venture fundable or are companies that, with a seed investment, will be sustainable through customer revenue, follow-on funding, or other forms of corporate venture. For more information about TEDCO’s Seed Funds, visit https://www.tedcomd.com/funding/seed-funds.